K. Pose

Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.

S. Quirce, E. Villamañán, J. Domínguez-Ortega, 2022, Journal of investigational allergology & clinical immunology.

Tailored to patient 7 to 10 day lenalidomide desensitization protocol.

A. Fiandor, R. Cabañas, M. Lluch-Bernal, 2023, Journal of investigational allergology & clinical immunology.

Long COVID outcomes in an asthmatic cohort and its implications for asthma control

S. Quirce, P. Barranco, E. Villamañán, 2022, Respiratory Medicine.